Back
CEVA, Inc. 10K Form
Sell
27
CEVA
CEVA, Inc.
Last Price:
$20.90
Seasonality Move:
0.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | CEVA/CEVA, Inc. Quarterly |
| 2023-11-09 | 10Q | CEVA/CEVA, Inc. Quarterly |
| 2023-08-09 | 10Q | CEVA/CEVA, Inc. Quarterly |
| 2023-05-10 | 10Q | CEVA/CEVA, Inc. Quarterly |
| 2022-11-09 | 10Q | CEVA/CEVA, Inc. Quarterly |
| 2022-08-09 | 10Q | CEVA/CEVA, Inc. Quarterly |
Receive CEVA News And Ratings
See the #1 stock for the next 7 days that we like better than CEVA
CEVA Financial Statistics
Sales & Book Value
| Annual Sales: | $109.6M |
|---|---|
| Cash Flow: | $-6.3M |
| Price / Cash Flow: | 478.7 |
| Annual Sales: | $11.19 |
| Price / Book: | 2.17 |
Profitability
| EPS (TTM): | -0.44280 |
|---|---|
| Net Income (TTM): | $-10.6M |
| Gross Margin: | $95.4M |
| Return on Equity: | -3.78% |
| Return on Assets: | -3.29% |
CEVA, Inc. Earnings Forecast
Key CEVA, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for CEVA is 87.08%.
-
The Selling, General & Administrative Expenses for CEVA have been equal to 28.61% of Gross Profit Margin.
-
The Research & Development expenses have been 68.28% of Revenue.
-
The Net Earning history of CEVA is -9.71% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 16 years.
CEVA, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | CEVA |
| CUSIP: | 157210 |
| Website: | ceva-ip.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 9.93 |
| Quick Ratio: | 9.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 26.68 |
CEVA Technical Analysis vs Fundamental Analysis
Sell
27
CEVA, Inc. (CEVA)
is a Sell
Is CEVA, Inc. a Buy or a Sell?
-
CEVA, Inc. stock is rated a SellThe current CEVA, Inc. [CEVA] share price is $21.60. The Score for CEVA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.